/stocks — the workspaceLOADING

ETON · All filings · Read this filing

What changed 10-Q

Item 5. Other Information

2022-08-11 compared with 2022-05-12 · 17 added, 29 removed, 8 unchanged (85% of the section changed)

1 unchanged sentence

exhibits listed on the Exhibit Index are either filed or furnished with this report or incorporated herein by reference.

Credit Agreement by and among the Company, the Lenders party thereto, and SWK Funding LLC , as administrative agent dated as of November 13, 2019 and conformed through Third Amendment dated as of April 5, 2022.

Asset Purchase Agreement by and among the Company and Dr.

Reddy’s Laboratories S.A., dated as of June 24, 2022.

Certification of President and Chief Executive Officer (Principal Executive Officer), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

2 unchanged sentences

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

The following financial

information from the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2022, formatted in Extensible Business

Reporting Language (XBRL):

(i) the Condensed Balance Sheets, (ii) the Condensed Statements of Operations, (iii) the Condensed Statements

of Stockholders’ Equity, (iv) the Condensed Statements of Cash Flows and (v) Notes to Condensed Financial Statements.

Inline XBRL Instance Document

Inline XBRL Taxonomy Extension

Schema Document

Inline XBRL Taxonomy Extension

Calculation Linkbase Document

Inline XBRL Taxonomy Extension

Definition Linkbase Document

Inline XBRL Taxonomy Extension

Label Linkbase Document

Inline XBRL Taxonomy Extension

Presentation Linkbase Document

Cover Page Interactive Data

File (embedded within the Inline XBRL document)

These certifications are

being furnished solely to accompany this quarterly report pursuant to 18 U.S.C.

Section 1350, and are not being filed for purposes

of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of

the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

following financial information from the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2022 formatted

in Extensible Business Reporting Language (XBRL):

(i) the Condensed Balance Sheets, (ii) the Condensed Statements of Operations,

(iii) the Condensed Statements of Stockholders’ Equity, (iv) the Condensed Statements of Cash Flows and (v) Notes to Condensed

Financial Statements.

certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C.

Section 1350, and are not being

filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference

into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language

in such filing.

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned thereunto duly authorized.

ETON PHARMACEUTICALS, INC.

President and Chief Executive Officer

(Principal Executive Officer)

Chief Financial Officer

(Principal Financial Officer)

PHARMACEUTICALS, INC.

and Chief Executive Officer

Executive Officer)

Financial Officer

Financial Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.